AGP Picks
View all

RNA isolation and enrichment products market seen reaching $10.54B by 2030

Sep. 22, 2026
By AI, Created 18:45 UTC, Sep 22, 2026, AGP -

The RNA isolation and enrichment products market is projected to grow from $6.35 billion in 2025 to $10.54 billion by 2030, driven by genomics research, precision medicine and wider use of next-generation sequencing. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - RNA isolation and enrichment products sit at the center of molecular biology and genomics workflows. - Demand for high-quality RNA supports sequencing, transcriptomics, gene expression analysis and diagnostic testing. - The market’s growth tracks broader investment in precision medicine and advanced biomarker discovery.

What happened: - The Business Research Company released a global market report on RNA isolation and enrichment products covering 2026-2035. - The market was valued at $6.35 billion in 2025. - The market is projected to reach $7.05 billion in 2026, a CAGR of 11.0%. - The market is forecast to reach $10.54 billion by 2030, at a CAGR of 10.6%. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Early growth was driven by rising use of molecular biology techniques in research labs. - Genomic and transcriptomic research expansion also supported demand. - Funding gains in life sciences and biotech added to market growth. - Column-based RNA extraction methods saw early adoption. - Researchers increased demand for precise gene expression analysis tools. - Future growth is expected from precision medicine and personalized diagnostics. - Wider adoption of next-generation sequencing is also expected to lift demand. - Single-cell and spatial transcriptomics research is expanding. - Automated laboratory workflows and robotics are advancing. - Investment in biomarker discovery platforms is increasing. - The report highlights automated RNA extraction platforms integrated with robotics. - High-purity RNA isolation kits tailored for NGS workflows are gaining preference. - Magnetic bead-based purification technologies are increasing use because of yield and efficiency gains. - Low-input and single-cell RNA isolation solutions are expanding. - RNA workflows are being integrated into high-throughput drug discovery and biomarker identification. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - The report says genomics research is a major driver of the market. - Genomics research includes studying genes, sequencing RNA and understanding molecular interactions. - Precision medicine is expanding the need for genomics research. - RNA isolation and enrichment products provide high-quality RNA for sequencing, transcriptomics and gene expression analyses. - That supports more accurate and reliable molecular research outcomes. - An ASGCT report in July 2023 said gene therapy candidates in Phase II trials rose from 247 in Q1 2023 to 260 by Q2 2023, a 5% increase.

Between the lines: - The forecast suggests the market is moving from broad research use toward more specialized clinical and high-throughput applications. - Automation and low-input workflows point to a shift toward faster processing, smaller sample volumes and more standardized lab operations. - North America’s lead reflects an established research base, while Asia-Pacific’s faster growth signals broader geographic expansion in genomics capacity.

What's next: - Growth will likely depend on continued adoption of NGS, single-cell analysis and automated RNA handling systems. - The market should benefit if precision medicine and biomarker discovery remain priority areas for life sciences spending. - The company is offering a free sample and the full report for further detail.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Market Forecast Analysis

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Market Forecast Analysis

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.